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J.F. Thompson*Exeter Vascular Service, Royal Devon and Exeter NHS Foundation Trust and Peninsula Medical School,
Exeter EX2 5DW, UKBackground. It is traditionally taught that a pneumatic tourniquet is contraindicated for trans-tibial amputations in
patients with peripheral arterial disease. However, tourniquets are used successfully during total knee arthroplasty in elderly
patients. Vascular patients undergoing a trans-tibial amputation have a high perioperative mortality and morbidity—
notably the need for wound revision or a higher amputation level. We hypothesised that a tourniquet, used during
amputation, would reduce blood loss and subsequent complications without compromising healing.
Methods. This was a prospective non-randomized study of 89 adult patients who underwent a trans-tibial amputation
between January 2001 and December 2003. The endpoints were: haemoglobin levels, the need for blood transfusion,
perioperative morbidity, revision rate and mortality. Patients were divided into two groups: a group with a pneumatic
tourniquet (nZ42) and a group without (nZ47).
Results. The haemoglobin fall was 14.8% in the non-tourniquet group and 5.6% in the tourniquet group, with a higher need
for transfusion in the non-tourniquet group. The revision rate was 14.3% in the tourniquet group and significantly higher in
the non-tourniquet group (38.3%). Mortality was similar in both groups: 7.1% for the tourniquet and 6.4% for the non-
tourniquet group.
Conclusion. The use of a pneumatic tourniquet is safe and significantly reduces both blood loss and transfusion
requirements during trans-tibial amputation. A pneumatic tourniquet reduces revision rates by over 50%, with subsequent
cost savings.Keywords: Pneumatic tourniquet; Trans-tibial amputation; Below knee amputation; Blood transfusion.Introduction
Trans-tibial amputation is a hazardous operation in
vascular surgery, because the patients are elderly,
usually unwell and have serious co-morbidity such as
diabetes, renal failure and ischaemic heart disease,
with many deaths due to myocardial infarction.1
Bleeding is well known to be an independent predictor
of perioperative mortality in surgery as a whole,2 but
even more so in vascular patients.3
Pneumatic tourniquets have been used for many
years in orthopaedics and trauma. Patients undergoing
knee arthroplasty are often elderly and have significant
co-morbidity, particularly as an ageing population
demands an operation which can help maintain their
independence. Although most orthopaedic surgeons
look out for severe peripheral vascular disease as aing author. Mr J.F. Thompson, Exeter Vascular Service,
and Exeter NHS Foundation Trust and Peninsula
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actuallymeasure ankle pressures and very fewpatients
are referred for a vascular opinion. Despite this, there is
no indication that liberal use of tourniquets leads to
problems with wound healing, deep venous thrombo-
sis or distal tissue loss. Bruce et al. concluded that it is
safe to proceed with surgery using a tourniquet in
patientswith impalpable foot pulses or claudication, as
long as the femoral pulse is palpable and there is no
active ulceration or rest pain.4
We hypothesised that use of a pneumatic tourniquet
might improve the outcome following trans-tibial
amputation, without compromising wound healing in
a population of elderly patients with atherosclerosis.Methods
This was an audit of a pilot study where a standard
orthopaedic tourniquet was used, inflated to twice
the systolic blood pressure. The tourniquet wasEur J Vasc Endovasc Surg 31, 642–645 (2006)
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Table 2. Results
Group Tourniquet Non-tourniquet p-Value
Haemoglobin fall (%) 5.6 14.8 !0.0001
Transfusion rate (%) 2.4 42.6 !0.001
Morbidity (%) 11.9 8.5 NS
Revision rate (%) 14.3 38.3 !0.025
Mortality (%) 7.1 6.4 NS
Tourniquets and BKA 643introduced for a trial period by each of three
consultant vascular surgeons and initial impressions
were discussed at weekly morbidity and mortality
meetings. The technique was then shown to trainee
surgeons; thereafter the choice of tourniquet was
largely based on availability and personal preference.
After approximately 100 amputations had been
performed the outcomes were audited. Wound com-
plications, revision, morbidity and deaths had been
recorded prospectively and were verified weekly at a
meeting of all three vascular surgeons and their teams.
All patients’ records were then scrutinised to revali-
date these data. Blood transfusion data were obtained
from the laboratory computer records and changes in
haemoglobin concentration from the notes and
computer records. Estimates of surgical blood loss
are subjective and unreliable and were not included in
the analysis.
A transfusion protocol was in force, with a trigger of
8 g/dL for vascular patients and a target haemoglobin
concentration no less than 10 g/dL.
Differences were subject to analysis of variance;
non-parametric data were analysed using the Mann–
Whitney test. Categorical data were compared using
the chi-squared test. It should be noted that the
analysis was on an ‘intention to treat’ basis.Results
Between January 2001 and December 2003, 89 patients
underwent a trans-tibial amputation and 42 had a
tourniquet applied. The patients’ ages were a median
76 years (range, 41–88 years) in the tourniquet group
and 72 years (range, 26–89 years) in the non-tourniquet
group. All patients had end stage peripheral vascular
disease (Fontaine III and IV). Patient demographics
were well matched, with more males in the tourniquet
group (Table 1). There were no complications associ-
ated with the use of the tourniquet and in particular no
deep vein thrombosis or acute postoperative skin flap
necrosis. The use of a tourniquet did not influence the
above knee to below knee amputation ratio in our unit.
We did use the tourniquet for Gritti Stokes and aboveTable 1. Demographics
Group Tourniquet Non-tourniquet p-Value
Number of patients 42 47 NS
Median age (years) 76 72 NS
Sex (M/F) 28/14 25/22 NS
Diabetes mellitus (%) 45.2 48.9 NS
Hypertension (%) 59.5 61.7 NS
Chronic renal failure (%) 4.8 4.3 NSknee amputations when possible, but the numbers
were small and we wanted to study two comparable
groups. In two patients with heavy arterial calcifica-
tion and patent superficial femoral arteries, the
tourniquet failed, so it was deflated to overcome the
pure venous occlusion.
Mean preoperative haemoglobin was 11.3 g/dL in
the tourniquet group versus 11.0 g/dL in the non-
tourniquet group. The postoperative haemoglobin fall
was 5.6% (to 10.6 g/dL) in the tourniquet group and
14.8% (to 9.3 g/dL) in the non-tourniquet group (p!
0.0001). Only one patient (2.4%) was transfused two
units of packed cells in the tourniquet group. In the
non-tourniquet group, however, 20 patients (42.6%)
needed a blood transfusion (Table 2). In total 47 units
of packed cells were transfused; a median of one unit
per patient. The need for transfusion was significantly
higher in the non-tourniquet group (p!0.001).
Postoperative morbidity rates were similar in the
two groups (Table 3). Six patients (14.3%) in the
tourniquet group needed a stump revision and five of
these went on to trans-femoral amputation (11.9%). In
contrast, 18 patients (38.3%) in the non-tourniquet
group needed a stump revision, and half of them
required a trans-femoral amputation (19.2%). These
postoperative revision rates were significantly higher
in the non-tourniquet group compared to the tourni-
quet group (p!0.025). There was no difference in the
grade of surgeon performing the original amputation
in the subgroup requiring revision.
Three patients died in each group (tourniquet
group 7.1% and non-tourniquet group 6.4%). One
death was related to the primary amputation in the
tourniquet group and two were in the non-tourniquet
patients (Table 4).Table 3. Morbidity
Group Tourniquet Non-tourniquet
Pulmonary oedema 1
Pulmonary embolus 1
Clostridium difficile diarrhoea 2 1
Acute myocardial infarct 1 1
Urinary tract infection 1
Cerebrovascular accident 1
Total 5 (11.9%) 4 (8.5%)
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Table 4. Mortality
Group Tourniquet Non-tourniquet
Postoperative (30-day) 1 2
Death after revision
procedure
1 1
Disseminated ovarian
cancer
1
Total 3 (7.1%) 3 (6.4%)
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The effect of a tourniquet on reducing perioperative
blood loss during total knee arthroplasty is, somewhat
surprisingly, unclear. There has been a trend towards
the use of tourniquets to reduce blood loss and to give
the surgeon a better perioperative view,5,6 but recent
reports question their effectiveness and there is also
evidence against their use.7,8 With regard to the timing
of tourniquet release, three recent reports suggest that
this should be done postoperatively.9–11
In varicose vein surgery a tourniquet reduces blood
loss and improves cosmesis, without affecting com-
plications or morbidity.12–14 In the management of
burns, tourniquets can be used without affecting skin
graft viability.15,16
We acknowledge that selection bias may be present
in this series, but reiterate that the decision to use a
tourniquet was due to availability or simply remem-
bering to use it. Patients with a high body mass index
were not excluded from tourniquet use (they might be
expected to have a higher complication rate). The
differences in blood transfusion and revision rate were
of such a magnitude that the advantages of the
pneumatic tourniquet appear clear, but a randomised
trial would support this impression.
Although, the tourniquet reduced transfusion
requirements—a total of 45 units of blood in this series
at a cost of £135 per unit—this did not translate into a
reduction in cardiac morbidity, perhaps due to either a
type II statistical error or falling rates of myocardial
infarction, due to improved anaesthetic techniques
and perioperative management. The overall mortality
rate is gratifying when compared to published rates in
the literature. Blood transfusion itself is associated
with an increase in perioperative infection rates,17
which may be one factor implicated in the higher
revision rates in the non-tourniquet group.
Revision to a transfemoral amputation has major
implications both for the patient, who is less likely to
proceed to limb fitting and independence, and to the
community, with the need for modifications to the
home or even rehousing.18 The precise reason why a
tourniquet should profoundly improve revision ratesEur J Vasc Endovasc Surg Vol 31, June 2006was not addressed by this pilot study, but is a potent
area for future research. The dry surgical field
obtained with a tourniquet enables the surgeon to
perform a neat, precise amputation without compro-
mising skin flap viability. It may also reduce haema-
toma formation, which is a potent cause of stump
breakdown. The only potential problem we can
envisage is in the rare case of a functioning infra-
inguinal vein graft, where it would be wise to avoid
the use a tourniquet.
In summary, the use of a pneumatic tourniquet is
safe and virtually eliminates blood loss and transfu-
sion requirements during trans-tibial amputation,
with no major drawbacks. Tourniquet use reduced
revision rates by over 50%, with a subsequent benefit
to the patient and cost savings to society.References
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